About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
Sustainable development/ESG“We help people live healthy lives in a healthy world”. This is our mission, which reflects Polpharma’s priorities. We provide patients with high-quality, effective, safe and accessible products while operating responsibly in the society, the environment and with respect to key stakeholders.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
Sebastian Szymanek President of the Management BoardHe has been associated with the pharmaceutical industry for 25 years. His professional experience includes working in both generic (AstaMedica, Lekam) and innovative companies (Fournier, AstraZeneca). He graduated from the Faculty of Pharmacy at the University of Wrocław, he completed his business education at the University of Management and Finance in Wrocław, Oxford Business School and London Business School.He has been associated with Polpharma since 2007, performing various roles in the commercial division. In 2014, he assumed the position of General Director in Poland. From 2017 to March 2021, he was the President of the Management Board of Polpharma Trade Office. From April 1, 2021, he was the Vice President of the Management Board of Pharmaceutical Works POLPHARMA S.A., and on September 1, 2021, he was appointed the President of the Management Board.
Wojciech Rosa Member of the Management BoardWojciech Rosa graduated from the Faculty of Economics and Management at the Koszalin University of Technology, Finance and Accounting at the University of Gdańsk, and obtained his MBA through the Gdańsk Foundation for Management Development (GFKM) from Erasmus University Rotterdam. He started his career in financial mathematics and capital investment strategies and in 2003 joined Polpharma Group as a financial controller for the Chemia Business Unit in Starogard Gdański. In subsequent years, he has played a key role in the area of domestic and international industrial operations as the Operational Controlling Director. In 2017, he assumed the position of Corporate Finance Director and is responsible for the finances of Polpharma Group in Poland.
Philip Fritzsche Member of the Management BoardPhilip Fritzsche joined Polpharma Group in 2019 as a Chief Procurement Officer. He brought to the company more than 20 years of experience in different companies within the pharmaceutical industry in various functions including assignments in Asia, Europe and USA. In addition to managing a modern and agile Sourcing and Procurement function across all group companies, he is also responsible for the cross functional External Supply Organization within Polpharma to ensure effective management of our external partners.
Andrzej Dziuban Member of the Management BoardAssociated with Polpharma since 1990, he began his career as a student at the Company-run “Polfa” School and later as an employee in the Environmental Protection Division. Currently, he is the Head of Benefits in the HR Department. In 2013, he was elected the employee representative to the Management Board of Zakłady Farmaceutyczne Polpharma S.A.He graduated from the Faculty of Management and Marketing at the University of Gdańsk and postgraduate studies in Psychology of Personnel Management at the University of Warsaw.
Dorota Chęć Member of the Management BoardDorota Chęć graduated from the Faculty of Economic Sciences and Management of the Nicolaus Copernicus University in Toruń, Postgraduate studies in Logistics and Supply Chain Management at the Poznań University of Economics and Executive MBA studies at the Kozminski University in Warsaw. She has been associated with Polpharma since the beginning of her career, which she started in the Marketing area as the Product Line Manager in the CNS Division. Later, she managed the logistics area in the Chemistry Business Unit in Starogard Gdański and supported the development of the Logistics area at Farmaprojects in Spain. In 2012, she became the Logistics Director at Polfa Warszawa, and since 2017 she has been responsible for Supply Chain Management in the Polpharma Group in Poland.
Agnieszka Deeg-Tyburska Member of the Management BoardAgnieszka Deeg-Tyburska has been linked with Polpharma for over 8 years. She heads the Legal, Security and Patents departments. From 2019 until now, she served as the Company’s proxy. A legal counsel by education, she specializes in M&A transactions of companies and products, in pharmaceutical law, and recently also in arbitration and mediation. She is a mediator certified by CEDR (London) and Vice Chair of the Legal Affairs Committee at Medicines for Europe. Agnieszka has a wealth of legal and business experience in Poland, CEE and CIS countries. In 2021, she was named among Top 25 Women Lawyers in Business by “Forbes Women”.
Agnieszka Milewczyk Member of the Management BoardAgnieszka Milewczyk graduated from the Warsaw School of Economics, earned an MBA from the Carlson School of Management/Minnesota University, and holds a PhD in Organizational Culture. She is an expert in leadership, organizational development, and talent management. For over 25 years, she has been involved in the pharmaceutical (J&J, Bristol Myers Squibb), FMCG and financial industries, gaining experience in the areas of strategy, marketing, sales and HR. Previously, she served as CEO of the consulting firm Hay Group Polska, where she promoted a modern approach to leadership development and building an organizational culture based on diversity and engagement. Before joining Polpharma Group in January 2025, she worked as HR head at Santander Bank in Spain.
Robert Knerr Member of the Management BoardRobert Knerr is a pharmacist by education (PhD in Pharmaceutical Technology) and holds an MBA in Pharma Management from the International School of Management in Dortmund. He is a Qualified Person under EU GMP regulations. With over 15 years of experience in the pharmaceutical industry, he has held leadership roles in R&D, Industrial Operations, and Portfolio and Product Development at companies such as STADA and Haupt Pharma (now Aenova). Before joining Polpharma Group in 2021, he served as Executive Vice President Global Portfolio and Product Development at STADA.
Thomas Nothegger Member of the Management BoardThomas Nothegger holds a PhD in Chemistry from the University of Innsbruck and an MBA from the Management Center Innsbruck. He has broad experience in Technical Operations, Product Development, Portfolio Management, and Quality Management, with a proven track record of successful operational turnarounds and customer-centric strategies. He has worked in multinational pharmaceutical companies across Europe, the US, Latin America, and Asia.
